Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Worm

Showing results (271-280 of 307) with videos related to

Pageof 31
Sort By:
Allergy|July 4, 2014
First European data from the network of severe allergic reactions (NORA)M Worm, A Moneret-Vautrin, K Scherer, et al.
Allergy|November 20, 2014
Effects of a structured educational intervention on knowledge and emergency management in patients at risk for anaphylaxisK Brockow, S Schallmayer, K Beyer, et al.
Clinical and Translational Allergy|November 10, 2016
Standardization of double blind placebo controlled food challenge with soy within a multicentre trialR Treudler, A Franke, A Schmiedeknecht, et al.
Allergy|February 21, 2013
Evaluation of commercial skin prick test solutions for selected occupational allergensV van Kampen, F de Blay, I Folletti, et al.
Allergy|July 4, 2017
Meat allergy associated with galactosyl-α-(1,3)-galactose (α-Gal)-Closing diagnostic gaps by anti-α-Gal IgE immune profilingU Jappe, S Minge, B Kreft, et al.
Allergy|November 21, 2013
Management of anaphylaxis: a systematic reviewS Dhami, S S Panesar, G Roberts, et al.
Arthritis Care & Research|June 1, 2019
Large Variability of Frequency and Type of Physical Therapy in Patients in the German Network for Systemic SclerosisD Belz, P Moinzadeh, G Riemekasten, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|September 8, 2018
[Decreased professional performance and quality of life in patients with moderate-to-severe atopic eczema : Results from the German atopic eczema registry TREATgermany]E Haufe, S Abraham, A Heratizadeh, et al.
The British Journal of Dermatology|December 29, 2015
The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodiesN Hunzelmann, G Riemekasten, M O Becker, et al.
The British Journal of Dermatology|October 1, 2020
Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2)A Wollenberg, A Blauvelt, E Guttman-Yassky, et al.
Pageof 31

Showing results (271-280 of 307) with videos related to

Sort By:
Pageof 31
Allergy|July 4, 2014
First European data from the network of severe allergic reactions (NORA)M Worm, A Moneret-Vautrin, K Scherer, et al.
Allergy|November 20, 2014
Effects of a structured educational intervention on knowledge and emergency management in patients at risk for anaphylaxisK Brockow, S Schallmayer, K Beyer, et al.
Clinical and Translational Allergy|November 10, 2016
Standardization of double blind placebo controlled food challenge with soy within a multicentre trialR Treudler, A Franke, A Schmiedeknecht, et al.
Allergy|February 21, 2013
Evaluation of commercial skin prick test solutions for selected occupational allergensV van Kampen, F de Blay, I Folletti, et al.
Allergy|July 4, 2017
Meat allergy associated with galactosyl-α-(1,3)-galactose (α-Gal)-Closing diagnostic gaps by anti-α-Gal IgE immune profilingU Jappe, S Minge, B Kreft, et al.
Allergy|November 21, 2013
Management of anaphylaxis: a systematic reviewS Dhami, S S Panesar, G Roberts, et al.
Arthritis Care & Research|June 1, 2019
Large Variability of Frequency and Type of Physical Therapy in Patients in the German Network for Systemic SclerosisD Belz, P Moinzadeh, G Riemekasten, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|September 8, 2018
[Decreased professional performance and quality of life in patients with moderate-to-severe atopic eczema : Results from the German atopic eczema registry TREATgermany]E Haufe, S Abraham, A Heratizadeh, et al.
The British Journal of Dermatology|December 29, 2015
The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodiesN Hunzelmann, G Riemekasten, M O Becker, et al.
The British Journal of Dermatology|October 1, 2020
Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2)A Wollenberg, A Blauvelt, E Guttman-Yassky, et al.
Pageof 31